EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines



Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines



Folia Biologica 46(1): 11-15



It has been found previously that irradiated, IL-2 gene-modified plasmacytoma (X63-m-IL-2) vaccines are more efficient in the therapy of the parental (X63-Ag8.653) plasmacytoma than live plasmacytoma vaccines. In this communication, we have demonstrated that irradiation of murine IL-2-producing plasmacytoma vaccines resulted in upregulation of CD80 molecule expression and IL-2 production. The expression of MHC class I antigens was not altered. The upregulation of the CD80 membrane molecule expression in X63-m-IL-2 cells was higher after irradiation with 150 Gy than after irradiation with 50 Gy. Comparable upregulation of the CD80 molecule expression has also been demonstrated after irradiation of the parental murine X63-Ag8.653 plasmacytoma cells. The results indicate that upregulation of the CD80 molecule expression and enhanced IL-2 production in irradiated X63-m-IL-2 cells was responsible for the higher therapeutic effectiveness of the irradiated plasmacytoma vaccine.

(PDF emailed within 1 workday: $29.90)

Accession: 010885640

Download citation: RISBibTeXText

PMID: 10730877



Related references

Irradiated IL-2 gene-modified plasmacytoma vaccines are more efficient than live vaccines. International Journal of Oncology 12(5): 1195-1198, 1998

The impact of vaccines and the future of genetically modified poxvirus vaccines for poultry. Animal Health Research Reviews 5(2): 263-266, 2005

The impact of vaccines and the future of genetically modified poxvirus vaccines for poultry. Animal Health Research Reviews 5(2): 263-266, 2004

Design of therapeutic and prophylactic preparations based on live genetically modified microorganisms. 1. Genetically modified microorganisms for the development of a new generation of immunobiological preparations and vaccines. Biotekhnologiya (5): 39-48, 2004

Genetically modified vaccines augment the efficacy of cancer surgery and chemotherapy. Folia Biologica 55(6): 199-200, 2010

Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy. Polskie Archiwum Medycyny Wewnetrznej 121(12): 461-466, 2012

Genetically modified tumours vaccines: Insertion of the IL-2 gene downregulates tumorigenicity more efficiently than insertion of the CD80 gene. International Journal of Oncology 10(1): 77-82, 1997

International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?. Cancer Research 64(18): 6827-6830, 2004

A new method for the production of potent inactivated vaccines with ultra-violet irradiation II Sterilization of bacteria and immunization with rabies and St Louis encephalitis vaccines. Jour Immunol Virus Res And Expt Chemother: 317-329, 1945

Comparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine model. Toxins 4(11): 1058-1081, 2013

Production of potent inactivated vaccines with ultraviolet irradiation II An abbreviated preliminary report on sterilization of bacteria and immunization with rabies and St Louis encephalitis vaccines. Jour Amer Med Assoc: 31-532, 1944

Antitumor therapeutic effects of e7 subunit and DNA vaccines in an animal cervical cancer model: antitumor efficacy of e7 therapeutic vaccines is dependent on tumor sizes, vaccine doses, and vaccine delivery routes. Dna and Cell Biology 25(5): 277-286, 2006

Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. Journal of Experimental Medicine 191(10): 1699-1708, 2000

Use of genetically modified viruses and genetically engineered virus-vector vaccines: environmental effects. Journal of Toxicology and Environmental Health. Part A 69(21): 1971-1977, 2006

Vaccinations And Vaccines Against Poliomyelitis. Indications And Results Of Killed Vaccines And Live Vaccines. Anales de la Real Academia Nacional de Medicina 80: 353-385, 1963